Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Dylan Speer
What To Know About Naked Shorting
|
Naked shorting is the illegal practice of short-selling shares that have not been affirmatively determined to exist. A naked short means a trader believes the future value of the stock will be worth so much less than its current value that they ask a broker to lend them artificial shares to further increase their position’s profitability.
Why Boston Scientific Shares Are Trading Higher Today
|
Boston Scientific (NYSE: BSX) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY21 EPS guidance with a midpoint above analyst estimates.
Why Translate Bio Shares Are Trading Higher Today
|
Translate Bio (NASDAQ: TBIO) shares are trading 9.5% higher after Roth Capital Partners raised its price target on the stock from $28 to $45.
Why India Globalization Capital Shares Spiked Today
|
India Globalization Capital (AMEX: IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.
Why Lyft Stock Is Trading Higher Today
|
Lyft, Inc. (NASDAQ: LYFT) shares are trading higher after the company announced it is collaborating with Argo AI and Ford Motor Company (NYSE: F) to launch self-driving vehicles on the Lyft network by the end of 2021.</
Why Diamondback Energy Stock Is Trading Higher Today
|
Diamondback Energy (NASDAQ: FANG) shares are trading higher after KeyBanc maintained an Overweight rating on the stock and raised its price target from $102 to $104.
Why Sorrento Therapeutics' Stock Is Trading Higher Today
|
Sorrento Therapeutics (NASDAQ: SRNE) shares are trading higher after the company announced dosing of COVID-19 patients in its Phase 2 clinical trial for COVIDROPS, a neutralizing antibody against SARS-CoV-2.
Why Chembio Diagnostics Shares Are Trading Higher Today
|
Chembio Diagnostics (NASDAQ: CEMI) shares are trading higher after the company announced it received a $28.3 million purchase order from Bio-Manguinhos for its DPP SARS-CoV-2 antigen tests in Brazil.
